Close this search box.

Safe and Effective Stereotactic Body Radiation Therapy (SBRT) for High-Risk Prostate Cancer Patients: 4-year Outcomes of a Phase II Trial

November 20, 2018

Victor Macias Hernandez, M.D., Ph.D.
Salamanca University Hospital; Valladolid University Hospital – Spain 

Hear about the outcomes from a novel, extreme hypofractionated approach (SBRT) to prostate cancer treatment using TomoTherapy®